DK164280C - 1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents

1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse

Info

Publication number
DK164280C
DK164280C DK542684A DK542684A DK164280C DK 164280 C DK164280 C DK 164280C DK 542684 A DK542684 A DK 542684A DK 542684 A DK542684 A DK 542684A DK 164280 C DK164280 C DK 164280C
Authority
DK
Denmark
Prior art keywords
carbon atoms
imidazooe4
caaquinoline
derivative
connection
Prior art date
Application number
DK542684A
Other languages
Danish (da)
English (en)
Other versions
DK164280B (da
DK542684A (da
DK542684D0 (da
Inventor
John F Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of DK542684D0 publication Critical patent/DK542684D0/da
Publication of DK542684A publication Critical patent/DK542684A/da
Publication of DK164280B publication Critical patent/DK164280B/da
Application granted granted Critical
Publication of DK164280C publication Critical patent/DK164280C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Alarm Systems (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Lubricants (AREA)
  • Luminescent Compositions (AREA)
DK542684A 1983-11-18 1984-11-15 1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse DK164280C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55315783A 1983-11-18 1983-11-18
US55315883A 1983-11-18 1983-11-18
US55315783 1983-11-18
US55315883 1983-11-18

Publications (4)

Publication Number Publication Date
DK542684D0 DK542684D0 (da) 1984-11-15
DK542684A DK542684A (da) 1985-05-19
DK164280B DK164280B (da) 1992-06-01
DK164280C true DK164280C (da) 1992-11-30

Family

ID=27070262

Family Applications (6)

Application Number Title Priority Date Filing Date
DK542684A DK164280C (da) 1983-11-18 1984-11-15 1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK135791A DK169179B1 (da) 1983-11-18 1991-07-16 1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK136191A DK164452C (da) 1983-11-18 1991-07-16 3-nitroquinolinderivat
DK136091A DK164451C (da) 1983-11-18 1991-07-16 3-aminoquinolinderivat
DK135891A DK164455C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-4-chlorforbindelser
DK135991A DK165921C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-5-oxyforbindelser

Family Applications After (5)

Application Number Title Priority Date Filing Date
DK135791A DK169179B1 (da) 1983-11-18 1991-07-16 1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK136191A DK164452C (da) 1983-11-18 1991-07-16 3-nitroquinolinderivat
DK136091A DK164451C (da) 1983-11-18 1991-07-16 3-aminoquinolinderivat
DK135891A DK164455C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-4-chlorforbindelser
DK135991A DK165921C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-5-oxyforbindelser

Country Status (15)

Country Link
EP (2) EP0310950B1 (cs)
JP (1) JPS60123488A (cs)
KR (1) KR900005657B1 (cs)
AT (2) ATE84525T1 (cs)
AU (2) AU581190B2 (cs)
CA (1) CA1271477A (cs)
DE (3) DE3481124D1 (cs)
DK (6) DK164280C (cs)
ES (1) ES537677A0 (cs)
IE (1) IE57874B1 (cs)
IL (2) IL84537A (cs)
NL (2) NL980041I2 (cs)
NO (7) NO163819C (cs)
NZ (1) NZ210228A (cs)
PH (1) PH22338A (cs)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) * 1988-02-16 1995-06-20 Susumu Takada 2-substituted carbonylimidazo¬4,5-c|quinolines
US5019574A (en) * 1988-09-30 1991-05-28 Chugai Seiyaku Kabushiki Kaisha 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
DE69029212T2 (de) * 1989-02-27 1997-05-22 Riker Laboratories Inc 4-Amino-1H-Imidazo(4,5-c)chinoline als antivirale Mittel
CA2011504C (en) * 1989-03-07 1998-06-02 Kenji Ohmori Imidazoquinolone derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
JP2988692B2 (ja) * 1989-07-18 1999-12-13 協和醗酵工業株式会社 イミダゾキノロン誘導体
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) * 1989-11-07 1992-02-28 Simond Jacques Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
EP0459505B1 (en) * 1990-06-01 1996-10-02 Kyowa Hakko Kogyo Co., Ltd. Imidazonaphthyridine derivatives
HU222250B1 (hu) * 1991-03-01 2003-05-28 Minnesota Mining And Manufacturing Company 1- és 2-helyzetben szubsztituált 1H-imidazo[4,5-c]kinolin-4-amin-származékok előállításában alkalmazható intermedierek
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5693811A (en) * 1996-06-21 1997-12-02 Minnesota Mining And Manufacturing Company Process for preparing tetrahdroimidazoquinolinamines
WO1998030562A1 (en) * 1997-01-09 1998-07-16 Terumo Kabushiki Kaisha Novel amide derivatives and intermediates for the synthesis thereof
JPH10298181A (ja) * 1997-04-25 1998-11-10 Sumitomo Pharmaceut Co Ltd タイプ2ヘルパーt細胞選択的免疫応答抑制剤
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd 1h―イミダゾピリジン誘導体
UA75622C2 (en) * 2000-12-08 2006-05-15 3M Innovative Properties Co Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
CA2463101A1 (en) * 2001-10-23 2003-05-01 Applied Research Systems Ars Holding N.V. Azole derivatives and pharmaceutical compositions containing them
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
EP1543002B1 (en) 2002-07-23 2006-08-30 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Preparation of 1h-imidazo 4,5-c|quinolin-4-amines via1h-imidazo 4,5-c|quinolin-4-phthalimide intermediates
HRP20050183A2 (en) 2002-07-26 2005-06-30 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Preparation of 1h-imidazo [4,5-c]quinolin-4-aminesvia novel 1h-imidazo [4,5-c]quinolin-4-cyano and 1h-imidazo [4,5-c]quinolin-4-carboxamide intermediates
TW200510412A (en) 2003-08-12 2005-03-16 3M Innovative Properties Co Oxime substituted imidazo-containing compounds
RU2006105101A (ru) 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Арилокси и арилалкиленокси замещенные имидазохинолины
US20050054665A1 (en) 2003-09-05 2005-03-10 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
CA2536530A1 (en) 2003-10-01 2005-04-14 Taro Pharmaceuticals U.S.A., Inc. Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
SG149828A1 (en) 2003-10-03 2009-02-27 3M Innovative Properties Co Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
ITMI20032121A1 (it) * 2003-11-04 2005-05-05 Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm Procedimento per la preparazione di imiquimod e suoi intermedi
WO2005048945A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
AU2004312508A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
ES2392647T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos tetracíclicos quirales que inducen la biosíntesis de interferón
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
JP2009504803A (ja) 2005-08-22 2009-02-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Tlrアゴニスト
EP2029597A4 (en) 2006-05-31 2011-11-23 Univ California purine analogs
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
EP2125007B9 (en) 2007-02-07 2014-04-16 The Regents of The University of California Conjugates of synthetic tlr agonists and uses therefor
EP2009002A1 (en) * 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
EP2396328A2 (en) 2009-02-11 2011-12-21 The Regents of The University of California Toll-like receptor modulators and treatment of diseases
ES2943385T3 (es) 2010-08-17 2023-06-12 3M Innovative Properties Company Compuesto modificador de la respuesta inmunitaria lipidada y su uso médico
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
AU2012318694B2 (en) * 2011-10-04 2016-12-22 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
PL2950649T3 (pl) 2013-02-01 2020-11-02 Wellstat Therapeutics Corporation Związki aminowe o działaniu przeciwzapalnym, przeciwgrzybiczym, przeciwpasożytniczym i przeciwnowotworowym
US9512120B2 (en) 2013-03-15 2016-12-06 Syngenta Participations Ag Microbicidally active imidazopyridine derivatives
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
US9827329B2 (en) 2014-01-10 2017-11-28 Birdie Biopharmaceuticals, Inc. Compounds and compositions for immunotherapy
EP4001311B1 (en) 2014-07-09 2025-11-05 Birdie Biopharmaceuticals Inc. Anti-pd-l1/pd-1 combinations for treating tumors
WO2017046675A1 (en) * 2015-09-14 2017-03-23 Pfizer Inc. Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 用于治疗肿瘤的抗-egfr组合
CN115554406A (zh) 2016-01-07 2023-01-03 博笛生物科技有限公司 用于治疗肿瘤的抗-cd20组合
CA3021349A1 (en) 2016-04-19 2017-10-26 Innate Tumor Immunity, Inc. Nlrp3 modulators
US10533007B2 (en) 2016-04-19 2020-01-14 Innate Tumor Immunity, Inc. NLRP3 modulators
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh) 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
CN108794467A (zh) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-氨基-喹啉衍生物
KR20200019226A (ko) 2017-06-23 2020-02-21 버디 바이오파마슈티칼즈, 인크. 약학 조성물
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
CA3199650A1 (en) * 2020-12-09 2022-06-16 David Michael Simpson Imidazoquinoline compound having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) * 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
RO86850B (ro) * 1982-05-03 1985-05-31 Eli Lilly And Company Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine

Also Published As

Publication number Publication date
DK165921C (da) 1993-06-28
DK135891D0 (da) 1991-07-16
IE57874B1 (en) 1993-05-05
DK135991D0 (da) 1991-07-16
EP0145340B1 (en) 1990-01-24
KR850003890A (ko) 1985-06-29
NO169437B (no) 1992-03-16
DK164280B (da) 1992-06-01
NL980041I1 (nl) 1999-02-01
NO890826L (no) 1985-05-20
ES8603477A1 (es) 1985-12-16
NO890823L (no) 1985-05-20
IL84537A0 (en) 1988-04-29
JPH0586391B2 (cs) 1993-12-10
NO890825D0 (no) 1989-02-27
NO844565L (no) 1985-05-20
NO165146B (no) 1990-09-24
DK169179B1 (da) 1994-09-05
EP0310950A1 (en) 1989-04-12
DK136191D0 (da) 1991-07-16
DK135791D0 (da) 1991-07-16
NO165145B (no) 1990-09-24
DK164451C (da) 1992-11-09
CA1271477A (en) 1990-07-10
NO168705B (no) 1991-12-16
NO890824L (no) 1985-05-20
NZ210228A (en) 1989-01-27
DK135991A (da) 1991-07-16
NO890823D0 (no) 1989-02-27
DE3481124D1 (de) 1990-03-01
DE3486043T2 (de) 1993-06-03
DK136191A (da) 1991-07-16
ATE49763T1 (de) 1990-02-15
NO890822L (no) 1985-05-20
DK542684A (da) 1985-05-19
DK165921B (da) 1993-02-08
ES537677A0 (es) 1985-12-16
DK136091A (da) 1991-07-16
DK164455C (da) 1992-11-16
NO165145C (no) 1991-01-02
DK542684D0 (da) 1984-11-15
NO169437C (no) 1992-06-24
AU611997B2 (en) 1991-06-27
DK135891A (da) 1991-07-16
AU581190B2 (en) 1989-02-16
DK164452C (da) 1992-11-09
IL84537A (en) 1990-12-23
DK164455B (da) 1992-06-29
DK164452B (da) 1992-06-29
NO1999015I1 (no) 1999-07-08
EP0145340A3 (en) 1986-06-11
AU2991189A (en) 1989-06-15
JPS60123488A (ja) 1985-07-02
NO890824D0 (no) 1989-02-27
DE3486043D1 (de) 1993-02-25
NO168705C (no) 1992-03-25
EP0145340A2 (en) 1985-06-19
KR900005657B1 (ko) 1990-08-03
EP0310950B1 (en) 1993-01-13
IE842952L (en) 1985-05-18
NL980043I1 (nl) 1999-02-01
DE19975027I2 (de) 2000-09-21
NO890825L (no) 1985-05-20
PH22338A (en) 1988-08-12
DK136091D0 (da) 1991-07-16
DK164451B (da) 1992-06-29
NO165146C (no) 1991-01-02
NL980041I2 (nl) 1999-07-01
ATE84525T1 (de) 1993-01-15
NO890822D0 (no) 1989-02-27
NO163819B (no) 1990-04-17
DK135791A (da) 1991-07-16
NO165147B (no) 1990-09-24
NO163819C (no) 1990-08-01
NO165147C (no) 1991-01-02
NO890826D0 (no) 1989-02-27
AU3540284A (en) 1985-05-23

Similar Documents

Publication Publication Date Title
DK164280C (da) 1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse

Legal Events

Date Code Title Description
PUP Patent expired